Back
Apyx Medical 10K Form
Buy
61
APYX
Apyx Medical
Last Price:
1.60
Seasonality Move:
12.39%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | APYX/Apyx Medical Quarterly |
| 2020-05-11 | 10Q | APYX/Apyx Medical Quarterly |
| 2020-05-08 | 10Q | APYX/Apyx Medical Quarterly |
| 2020-03-31 | 10K | APYX/Apyx Medical Annual |
| 2019-11-15 | 10Q | APYX/Apyx Medical Quarterly |
| 2019-08-07 | 10Q | APYX/Apyx Medical Quarterly |
Receive APYX News And Ratings
See the #1 stock for the next 7 days that we like better than APYX
APYX Financial Statistics
Sales & Book Value
| Annual Sales: | $52.35M |
|---|---|
| Cash Flow: | $-6.38M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.58 |
| Price / Book: | 2.74 |
Profitability
| EPS (TTM): | -0.66000 |
|---|---|
| Net Income (TTM): | $-22.81M |
| Gross Margin: | $33.76M |
| Return on Equity: | -74.09% |
| Return on Assets: | -34.7% |
Apyx Medical Earnings Forecast
Key Apyx Medical Financial Ratios
- The Gross Profit Margin over the past 29 years for APYX is 64.49%.
- The Selling, General & Administrative Expenses for APYX have been equal to 93.35% of Gross Profit Margin.
- The Research & Development expenses have been 9.25% of Revenue.
- The Interest Expense is -13.24% of Operating Income.
- The Net Earning history of APYX is -35.75% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 12 years.
Apyx Medical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | APYX |
| CUSIP: | 03837C |
| Website: | apyxmedical.com |
Debt
| Debt-to-Equity Ratio: | 1.65 |
|---|---|
| Current Ratio: | 5.87 |
| Quick Ratio: | 4.71 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
APYX Technical Analysis vs Fundamental Analysis
Buy
61
Apyx Medical (APYX)
is a Buy
Is Apyx Medical a Buy or a Sell?
-
Apyx Medical stock is rated a Buy
The current Apyx Medical [APYX] share price is $1.60. The Score for APYX is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.